Full-Time

Lead Data Privacy Engineer

Deadline 9/30/26
CVS Health

CVS Health

10,001+ employees

Healthcare, insurance, PBM, and retail pharmacy

Compensation Overview

$106.6k - $284.3k/yr

+ Bonus + Commission + Short-term incentive + Equity award

Company Historically Provides H1B Sponsorship

California, USA

Remote

Bachelor's

Category
Cybersecurity (1)
Required Skills
Microsoft Azure
Python
NoSQL
Threat modeling
SQL
Java
Infrastructure as Code (IaC)
AWS
Go
Cryptography
Data Governance
DevOps
HIPAA
Google Cloud Platform

Get referred to CVS Health

See people who can refer or advise you

Requirements
  • Seven or more years of experience advancing Privacy Engineering, Security Engineering, Data Protection, Cybersecurity, or related technical disciplines, including architecting and implementing privacy and data protection controls aligned to GDPR, CCPA/CPRA, HIPAA, and similar regulatory frameworks.
  • Five or more years of experience designing and deploying enterprise-scale data protection capabilities, including encryption, tokenization, key management, data classification, Data Loss Prevention, privacy-enhancing technologies, and insider risk controls.
  • A strong software engineering foundation with five or more years developing, integrating, and automating solutions using Python, Java, Go, or similar programming and scripting languages.
  • Five or more years operating within cloud-native and DevSecOps environments, leveraging continuous integration and continuous delivery pipelines, Infrastructure as Code, security automation, privacy threat modeling, and privacy impact assessments to deliver secure, scalable solutions.
  • Three or more years leading complex, cross-functional privacy, data protection, cybersecurity, or compliance initiatives and influencing stakeholders across Engineering, Product, Data, Security, Legal, and Compliance organizations.
  • A Bachelor's degree from an accredited university or equivalent work experience consisting of a high school diploma and four years of relevant experience.
Responsibilities
  • Lead the strategy, prioritization, implementation, and continuous improvement of enterprise data protection and privacy engineering capabilities across structured and unstructured data environments, including enterprise data discovery, inventory, and data mapping initiatives.
  • Design, deploy, and optimize Privacy Enhancing Technologies, including encryption, tokenization, anonymization, pseudonymization, data classification, Data Loss Prevention, and other privacy-preserving solutions.
  • Partner with engineering, product, legal, compliance, and cybersecurity teams to embed privacy-by-design principles and translate regulatory requirements into scalable architectures, technical standards, governance controls, and enterprise data protection solutions.
  • Conduct privacy risk assessments, privacy impact assessments, threat modeling, and control evaluations to identify, mitigate, and monitor privacy and security risks while supporting audit, compliance, investigation, and regulatory obligations.
  • Drive enterprise data governance, privacy metrics, automation, advanced analytics, emerging privacy technologies, and continuous improvement initiatives by monitoring industry trends and regulatory developments and leading cross-functional teams to strengthen the organization's privacy posture, data protection effectiveness, and operational efficiency.
Desired Qualifications
  • Professional certifications such as CDPSE, CIPP, CIPT, CIPM, CISSP, or equivalent privacy and security credentials.
  • Knowledge of leading security, privacy, and compliance frameworks, including NIST, ISO 27001, HITRUST, FIPS, PCI DSS, and HIPAA, with exposure to regulatory audits, assessments, and remediation activities.
  • Expertise designing and securing cloud-native and data-driven environments, including AWS, Azure, GCP, SQL/NoSQL databases, data lakes, and enterprise-scale data platforms.
  • Demonstrated application of AI, automation, and advanced analytics to improve privacy, data protection, governance, and operational effectiveness.
  • Healthcare or other highly regulated industry background, with responsibility for protecting PHI, PII, and other sensitive or regulated data assets.

CVS Health operates as a diversified health services company in the United States, organized into Health Care Benefits, Pharmacy & Consumer Wellness, and Health Services. Its offerings include medical insurance products, retail and mail-order prescription drugs, and pharmacy benefit management (PBM) services, all connected through its integrated platform. By combining insurance, retail pharmacy, PBM, and health solutions, CVS Health coordinates care and controls costs across touchpoints for individuals, employers, and government programs. The company aims to lower health care costs while improving access and health outcomes for customers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Woonsocket, Rhode Island

Founded

1963

Get referred to CVS Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • CVS raised 2026 adjusted EPS guidance to $7.90-$8.10 on August 5, 2026.
  • CVS Caremark settled FTC probes July 14, 2026, reducing legal overhang.
  • CVS expanded Eli Lilly weight-loss access in early fourth quarter 2026.

What critics are saying

  • Louisiana's February 2026 $45 million settlement keeps PBM reform pressure on Caremark margins.
  • Aetna paid $117.7 million on March 11, 2026 for Medicare coding fraud allegations.
  • Federal and state antitrust actions threaten a Caremark-Aetna breakup by 2027.

What makes CVS Health unique

  • CVS integrates Aetna, Caremark, and 9,000 pharmacies across 87 million PBM members.
  • CVS combines retail, insurance, and PBM data under one operating system.
  • CVS launched Google Cloud partnerships and AI tools across claims, service, and engagement.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Company Equity

Wellness Program

Professional Development Budget

Paid Vacation

Paid Holidays

Company News

Yahoo Finance
Aug 28th, 2026
CVS stock down 12% in a month despite 34% annual gain, faces 2027 headwinds

CVS Health stock has declined 12.3% over the past month, sitting about 15% below its 52-week high, though it remains up 34% over the trailing twelve months. The company's revenue reached approximately $415 billion, up 7.4% year-over-year. Management raised its full-year 2026 adjusted earnings per share guidance by $0.60 to a range of $7.90 to $8.10. For 2027, the company anticipates membership declines at Caremark and continued 340B programme pressure, offset by Aetna's recovery, which added over $2 billion in adjusted operating income in the first half of 2026. Management considers a 2027 adjusted EPS outlook of at least $8.44 reasonable. Historically, CVS has experienced varied recovery periods following market downturns, with some rebounds taking years rather than months.

Yahoo Finance
Aug 25th, 2026
CVS and Roche stocks could benefit from expanding GLP-1 drug market

CVS Health and Roche could benefit from the growing GLP-1 drug market, alongside current leaders Eli Lilly and Novo Nordisk. CVS Health has improved its financial performance, with second-quarter revenue rising 7.3% year-over-year to $106.1 billion and adjusted earnings per share increasing 42.5% to $2.58. The pharmacy chain offers all approved GLP-1 medicines in the US, including Eli Lilly's Zepbound and Foundayo, plus Novo Nordisk's Wegovy. CVS also provides low-cost online consultations at $29 to assess patient eligibility for GLP-1 drugs. Beyond GLP-1 initiatives, CVS is addressing previous business challenges and is positioned to capitalise on rising healthcare spending in the US over the next decade.

Yahoo Finance
Aug 19th, 2026
CVS Health appoints JPMorgan data executive to board as focus shifts to digital healthcare

CVS Health has appointed Teresa Heitsenrether, a senior executive from JPMorgan Chase with extensive data and analytics experience, to its board of directors. The move follows the resignation of board member Larry M. Robbins. The appointment signals CVS Health's focus on technology and data-driven healthcare at the governance level. The company, valued at approximately $120bn, operates an integrated healthcare model spanning insurance, pharmacy benefits, and retail services. Heitsenrether's data expertise aligns with CVS Health's strategy to leverage digital capabilities and operational efficiency across its businesses, including Aetna and Caremark. The company faces challenges including high debt levels and reimbursement pressures in a competitive market alongside UnitedHealth Group and Cigna.

Yahoo Finance
Aug 14th, 2026
CVS Health beats Q2 revenue and profit estimates but faces questions on sustainability

CVS Health reported second quarter revenue of $106.1 billion, beating analyst estimates of $99.41 billion by 6.7%. Adjusted earnings per share came in at $2.58, surpassing expectations of $1.85 by 39.4%. Management attributed strong performance to specialty pharmacy and Medicare Advantage, with CEO David Joyner noting improvements from actions taken in Aetna and Caremark. The company raised its full-year adjusted EPS guidance to $8 at the midpoint. However, analysts raised concerns about sustainability. Management acknowledged ongoing challenges in the 340B program and normalisation of script share gains from Rite Aid. To offset these headwinds, executives pointed to biosimilars and investments in service technology. The company has committed $20 billion over a decade to AI and technology investments, with operational savings already being realised.

Fox Business
Aug 13th, 2026
Nine major PBMs to display TrumpRx prescription drug prices from 2027

Nine pharmacy benefit managers will integrate TrumpRx prescription drug pricing into their benefit tools, effective 1 January 2027. The Pharmaceutical Care Management Association and participating PBMs—including CVS Health, Express Scripts, Humana, and OptumRx—will display cash prices from TrumpRx alongside plan coverage costs. The agreement covers commercial, Medicare, and Medicaid plans. Patients will see TrumpRx prices for all listed drugs, whether through presidential deals or standard pricing. CMS Administrator Dr Mehmet Oz said the commitment will help patients compare prices and find better deals. PCMA CEO David Marin stated the transparency will allow consumers to make better-informed choices about prescription drug costs. Some PBMs will use Real Time Benefit Tools to display pricing comparisons, whilst others may employ different methods.